Long-Term Follow-up in Peripartum Cardiomyopathy Patients with Contemporary Treatment: Low Mortality, High Cardiac Recovery, but Significant Cardiovascular Co-Morbidities
Valeska Abou Moulig(Medizinische Hochschule Hannover), Johann Bauersachs(Medizinische Hochschule Hannover), Roman Pfister(University of Cologne), Tobias Koenig(Medizinische Hochschule Hannover), Christine S. Falk(Medizinische Hochschule Hannover), Tobias J. Pfeffer(Medizinische Hochschule Hannover), Christian Veltmann(University of Bremen), Stella Schlothauer(Medizinische Hochschule Hannover), Denise Hilfiker‐Kleiner(Medizinische Hochschule Hannover), David Duncker, Dominik Berliner(Medizinische Hochschule Hannover), Johannes Schwab(MRC Laboratory of Molecular Biology), Guido Michels(Sankt-Antonius-Hospital Eschweiler), Melanie Ricke‐Hoch(Medizinische Hochschule Hannover)
Cited by 81
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
Current State of Knowledge on Aetiology, Diagnosis, Management, and Therapy of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy
|European Journal of Heart Failure|2010|1.1k
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
|European Heart Journal|2022|1.1k
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767